Squadron Capital Management LLC Top Holdings and 13F Report (2026) About Squadron Capital Management LLCInvestment ActivitySquadron Capital Management LLC has $272.92 million in total holdings as of March 31, 2026.Squadron Capital Management LLC owns shares of 33 different stocks, but just 14 companies or ETFs make up 80% of its holdings.Approximately 38.50% of the portfolio was purchased this quarter.About 28.57% of the portfolio was sold this quarter.This quarter, Squadron Capital Management LLC has purchased 33 new stocks and bought additional shares in 8 stocks.Squadron Capital Management LLC sold shares of 8 stocks and completely divested from 15 stocks this quarter.Largest Holdings Relmada Therapeutics $58,983,014Cogent Biosciences $30,310,567KalVista Pharmaceuticals $26,171,013Kodiak Sciences $14,485,600ABIVAX SA $14,475,500 Largest New Holdings this Quarter 98943L107 - Zentalis Pharmaceuticals $9,432,540 Holding640268306 - NEKTAR THERAPEUTICS $8,993,750 Holding00704R109 - ADLAI NORTYE LTD $8,755,398 Holding75943R102 - Relay Therapeutics $8,183,875 Holding45166A102 - IDEAYA Biosciences $7,473,676 Holding Largest Purchases this Quarter Relmada Therapeutics 1,774,571 shares (about $12.35M)KalVista Pharmaceuticals 600,100 shares (about $12.08M)Zentalis Pharmaceuticals 4,031,000 shares (about $9.43M)NEKTAR THERAPEUTICS 125,000 shares (about $8.99M)ADLAI NORTYE LTD 1,265,231 shares (about $8.76M) Largest Sales this Quarter MAZE THERAPEUTICS INC 232,500 shares (about $6.94M)ARRIVENT BIOPHARMA INC 228,000 shares (about $5.26M)SPRUCE BIOSCIENCES INC 57,800 shares (about $3.78M)PALISADE BIO INC 1,500,000 shares (about $2.63M)ABIVAX SA 15,000 shares (about $1.67M) Sector Allocation Over TimeMap of 500 Largest Holdings ofSquadron Capital Management LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorRLMDRelmada Therapeutics$58,983,014$12,351,014 â–²26.5%8,474,57121.6%MedicalCOGTCogent Biosciences$30,310,567$288,367 â–²1.0%787,49211.1%MedicalKALVKalVista Pharmaceuticals$26,171,013$12,080,013 â–²85.7%1,300,1009.6%MedicalKODKodiak Sciences$14,485,600$3,365,615 â–²30.3%380,0005.3%MedicalABIVAX SA$14,475,500$1,670,250 â–¼-10.3%130,0005.3%SPONSORED ADSEWTXEdgewise Therapeutics$11,025,0000.0%350,0004.0%MedicalZNTLZentalis Pharmaceuticals$9,432,540$9,432,540 â–²New Holding4,031,0003.5%MedicalNEKTAR THERAPEUTICS$8,993,750$8,993,750 â–²New Holding125,0003.3%COM NEWADLAI NORTYE LTD$8,755,398$8,755,398 â–²New Holding1,265,2313.2%SPONSORED ADSRLAYRelay Therapeutics$8,183,875$8,183,875 â–²New Holding822,5003.0%MedicalMAZE THERAPEUTICS INC$7,686,375$6,940,125 â–¼-47.4%257,5002.8%COMIDYAIDEAYA Biosciences$7,473,676$7,473,676 â–²New Holding224,3002.7%MedicalSCYXSCYNEXIS$6,976,412$6,976,412 â–²New Holding7,608,6952.6%MedicalCCCCC4 Therapeutics$5,917,500$5,917,500 â–²New Holding2,250,0002.2%MedicalINHIBIKASE THERAPEUTICS INC$5,880,000$1,218,000 â–¼-17.2%3,500,0002.2%COM NEWPALISADE BIO INC$5,250,000$2,625,000 â–¼-33.3%3,000,0001.9%COMEUPRAXIA PHARMACEUTICALS INC$4,923,200$1,303,200 â–²36.0%680,0001.8%COMGHRSGH Research$4,569,500$140,600 â–²3.2%325,0001.7%MedicalKARYOPHARM THERAPEUTICS INC$4,177,500$4,177,500 â–²New Holding750,0001.5%COM NEWPROMIS NEUROSCIENCES INC$4,127,208$4,127,208 â–²New Holding324,9771.5%COM SHSLPCNLipocine$3,595,500$639,200 â–¼-15.1%450,0001.3%MedicalIVAInventiva$2,969,250$1,304,250 â–²78.3%535,0001.1%MedicalALXOALX Oncology$2,927,300$2,927,300 â–²New Holding1,460,0001.1%MedicalCNTXContext Therapeutics$2,882,000$2,882,000 â–²New Holding1,100,0001.1%MedicalNEXTCURE INC$2,830,200$299,403 â–²11.8%265,0001.0%COM NEWARRIVENT BIOPHARMA INC$2,537,700$5,259,960 â–¼-67.5%110,0000.9%COMSOL-GEL TECHNOLOGIES LTD$2,455,820$2,455,820 â–²New Holding31,0000.9%SHS NEWPASITHEA THERAPEUTICS CORP$1,557,7800.0%2,100,0000.6%COM NEWTRAWS PHARMA INC$936,437$369,342 â–¼-28.3%511,7140.3%COM NEWTXMDTherapeuticsMD$849,250$849,250 â–²New Holding420,4210.3%MedicalSPRUCE BIOSCIENCES INC$797,270$3,777,230 â–¼-82.6%12,2000.3%COM NEWHOWLWerewolf Therapeutics$469,199$469,199 â–²New Holding563,5350.2%MedicalNEUPHORIA THERAPEUTICS INC$312,283$312,283 â–²New Holding76,7280.1%COMTERNTerns Pharmaceuticals$0$7,676,000 â–¼-100.0%00.0%MedicalTARSTarsus Pharmaceuticals$0$6,550,400 â–¼-100.0%00.0%MedicalUPSTREAM BIO INC$0$6,262,148 â–¼-100.0%00.0%COMXENEXenon Pharmaceuticals$0$4,730,796 â–¼-100.0%00.0%MedicalDBV TECHNOLOGIES S A$0$4,600,800 â–¼-100.0%00.0%SPONSORED ADSCYBIN INC$0$4,294,500 â–¼-100.0%00.0%COM NEWBLTEBelite Bio$0$4,158,960 â–¼-100.0%00.0%MedicalVTYXVentyx Biosciences$0$3,702,300 â–¼-100.0%00.0%MedicalVERAVera Therapeutics$0$3,038,400 â–¼-100.0%00.0%MedicalWVEWAVE Life Sciences$0$2,975,000 â–¼-100.0%00.0%MedicalCMPSCompass Pathways$0$2,679,180 â–¼-100.0%00.0%MedicalAVALO THERAPEUTICS INC$0$2,360,800 â–¼-100.0%00.0%COM NEWZENAS BIOPHARMA INC$0$1,307,160 â–¼-100.0%00.0%COMNTLAIntellia Therapeutics$0$728,190 â–¼-100.0%00.0%MedicalELYMEliem Therapeutics$0$400,000 â–¼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
